Dr Gereon Lauer | Associate Director, Clinical Biomarkers
Vertex Pharmaceuticals Europe Ltd

Dr Gereon Lauer, Associate Director, Clinical Biomarkers, Vertex Pharmaceuticals Europe Ltd


1/2013-present Associate Director Clinical Biomarkers
Biomarker Lead Oncology and Neuro
VERTEX PHARMACEUTICALS (EUROPE) LTD, Abingdon, UK
- Clinical biomarker lead for Vertex’s UK based research and development projects
- Postulation and execution of biomarker strategies for projects in oncology and neurodegenerative diseases  

Previous positions
All positions at Takeda, Nycomed, Altana Pharma or Byk Gulden; based in Konstanz/DE
 
07/2010 -12/2012 Senior Group Leader – Biomarker Development
- Head of the Biomarker Development department
 
4/2008 – 7/2010 Senior Research Scientist/Biomarker Expert and Laboratory Team Leader
- Serving as Biomarker representative in different development projects in respiratory and auto-immune diseases (RA)
- Team leader of the biomarker laboratory  

6/2006 -3/2008 Laboratory Team Leader Functional Genomics
- Team leader of a service lab covering technology platforms like Luminex, qRT-PCR and Affymetrix GeneChips  

7/2000 – 6/2006 Laboratory Team Leader Biochemistry inflammation
- Heading of different lead discovery projects in the fields of intensive care, osteoarthritis, respiratory and immunology; 

back to speakers

Co-located with Biomarkers World Europe:

  • Exploratory Clinical Development World Europe 2015